Year of the authorized generic
Deficit Reduction Act (S 1932), which was signed into law Feb. 8, delays inclusion of "authorized generics" in "best price" calculations until Jan. 1, 2007. Both the House and Senate budget reconciliation bills originally set Jan. 1, 2006 as the date for the provision to take effect. The new "best price" formula could effectively end the practice of "authorized generics" (1"The Pink Sheet" Jan. 2, 2006, p. 25). Generic Pharmaceutical Association lauds the new formula, claiming that it would yield more than $150 mil. in savings over five years...
You may also be interested in...
The conference report on budget reconciliation creates a new definition of the Medicaid federal upper limit for pharmacy reimbursement for multiple source drugs
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.